Takeda Pharmaceutical Company Limited【JP:4502】Cash flow
Market cap
¥8.08T
P/E ratio
52.3x
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | - | - | - | - | - | 182,127 | 272,446 | 583,649 | 559,671 | 583,151 | 664,400 | 728,002 | 761,396 |
| Cash from operations | 330,520 | 148,720 | 182,517 | 25,491 | 261,363 | 377,854 | 328,479 | 669,752 | 1,010,931 | 1,123,105 | 977,156 | 716,344 | 1,057,182 |
| Capital expenditures | - | - | - | - | - | -67,005 | -77,677 | -127,082 | -111,206 | -123,252 | -140,657 | -175,420 | -200,795 |
| Cash from investing | -125,778 | -154,057 | 91,347 | -71,208 | -655,691 | -93,342 | -2,835,698 | 292,119 | 393,530 | -198,125 | -607,102 | -463,862 | -367,060 |
| Payments for dividends | - | - | - | - | - | -141,893 | -142,952 | -282,582 | -283,357 | -283,665 | -279,416 | -287,188 | -302,498 |
| Repurchases of common stock | - | - | - | - | - | -18,756 | -1,172 | -3,737 | -2,141 | -77,531 | -26,929 | -2,326 | -51,860 |
| Cash from financing | -155,442 | 96,502 | -300,998 | -124,839 | 289,896 | -326,226 | 2,946,237 | -1,005,213 | -1,088,354 | -1,070,265 | -709,148 | -354,416 | -751,425 |